Grade: Research grade
Patients should contact their provider if they experience signs of hypoglycemia (confusion, sweating, tremor, rapid heartbeat), particularly if taking tirzepatide concurrently with insulin or sulfonylureas, as dose adjustments of these medications may be necessary
However, we believe that there is no need to exaggerate: doses between 150 500 g a day ensure an optimal B12 supply in most people
Why Retatrutide Has Generated So Much Interest Over the past several years, metabolic medicine has undergone a dramatic shift
Patients should be aware that ongoing treatment is typically required to preserve the benefits. Nausea and Tolerance One of the common side effects when starting GLP-1 receptor agonists is nausea
Resources We Trust Cleveland Clinic: Ulcerative Colitis Mayo Clinic: Ulcerative Colitis National Institute of Diabetes and Digestive and Kidney Diseases: Ulcerative Colitis Crohns & Colitis Foundation: What Should I Eat With IBD